Literature DB >> 1848513

A retrospective study of spontaneous remission and long-term outcome in patients with infantile spasms.

R A Hrachovy1, D G Glaze, J D Frost.   

Abstract

The spontaneous remission rate and long-term outcome in 44 patients with infantile spasms not treated with hormonal drugs were studied. The cumulative spontaneous remission rate during the first 12 months after onset of infantile spasms, as determined by retrospective analysis, was as follows: 1 month, 2%; 2 months, 2%; 3 months, 5%; 4 months, 7%; 5 months, 9%; 6 months, 11%; 7 months, 11%; 8 months, 14%; 9 months, 16%; 10 months, 18%; 11 months, 25%; 12 months, 25%. The average age at follow-up was 80 months. Nine percent of patients had normal development or only mild impairment. The remainder showed various degrees of retardation. These data should be useful in the design and interpretation of therapeutic drug trials in patients with infantile spasms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848513     DOI: 10.1111/j.1528-1157.1991.tb05246.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  Treatment of infantile spasms: the ideal and the mundane.

Authors:  Tallie Z Baram
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

Review 2.  Infantile spasms.

Authors:  R E Appleton
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

3.  Model of cryptogenic infantile spasms after prenatal corticosteroid priming.

Authors:  Libor Velísek; Tamar Chachua; Mi-Sun Yum; Ka-Lai Poon; Jana Velísková
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

4.  Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  C Y Go; M T Mackay; S K Weiss; D Stephens; T Adams-Webber; S Ashwal; O C Snead
Journal:  Neurology       Date:  2012-06-12       Impact factor: 9.910

5.  Infantile Spasms.

Authors:  Mary L. Zupanc
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

Review 6.  Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis.

Authors:  T Z Baram
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

Review 7.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

8.  High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study.

Authors:  T Z Baram; W G Mitchell; A Tournay; O C Snead; R A Hanson; E J Horton
Journal:  Pediatrics       Date:  1996-03       Impact factor: 7.124

9.  West syndrome followed by juvenile myoclonic epilepsy: a coincidental occurrence?

Authors:  Salvatore Mangano; Rosaria Nardello; Gabriele Tripi; Giuliana Giordano; Chiara Spitaleri; Giuseppa Renata Mangano; Antonina Fontana
Journal:  BMC Neurol       Date:  2013-05-24       Impact factor: 2.474

10.  Sulthiame add-on therapy for epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; Philip Milburn-McNulty; Graham Powell; Graeme J Sills; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.